The Medical Research Foundation has invested £2.85m to create the only national PhD Training Programme that will train new scientists to explore ways to tackle antimicrobial resistance, one of the greatest emerging threats to human health.
Antibiotics transformed healthcare in the 20th century and are still considered one of the greatest medical achievements of the era. Today, we still rely on antibiotics to treat everything from minor cuts to life-threatening bacterial infections and to prevent infection after surgery. These drugs have drastically improved our quality of life and increased lifespan.
In the 21st century, antibiotic overuse and misuse has led to antibiotics rapidly becoming ineffective. Antimicrobial resistance, specifically antibiotic resistance, now poses a global threat to human life. We need urgent action to halt resistance and to accelerate new treatments for bacterial infection. The Medical Research Foundation’s Antimicrobial Resistance PhD Training Programme has been designed in response.
The strategic objectives of this national Training Programme are to develop a strong and active network of new researchers for the UK with multidisciplinary skills who will be able to develop, undertake and, potentially, lead AMR research which crosses the traditional boundaries between research disciplines and sectors.
The Programme will also fund training and cohort-building activities for a wider cohort of approximately 150 PhD students studying AMR across the UK.
The University of Bristol is leading this cross-institutional training programme. PhD students will be located at universities and research institutes across the UK.